7th Apr 2014 12:25
LONDON (Alliance News) - e-Therapeutics PLC Monday said that it had appointed Steve Medlicott as Chief Financial Officer, following the resignation of Daniel Elger with immediate effect, also announced Monday.
Medlicott had advised the company on its GBP40 million fund-raising in 2013. Medlicott previously worked as finance director at Waste2Tricity Ltd, and co-founded Blueprint Advisors Ltd in 2012.
Shares in the biotechnology company were trading down 0.5% at 22.88 pence Monday afternoon.
By Hana Stewart-Smith; [email protected]; @HanaSSAllNews
Copyright © 2014 Alliance News Limited. All Rights Reserved.
Related Shares:
ETX.L